A comparative assessment of ACS NSQIP-predicted and actual surgical risk outcomes of robotic transhiatal esophagectomy for esophageal adenocarcinoma resection at a high volume institution
Journal of Robotic Surgery · 2024
DOI: 10.1007/s11701-024-02034-1 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Robotic Surgery, 2024. Verfasst von Sharona B Ross und 5 weiteren Autor:innen. Beteiligte Einrichtung: Foregut and HPB Division, Digestive Health Institute, AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA. mysharonaross@g…. Hauptthemen laut MEDLINE: Esophagectomy, Esophageal Neoplasms, Robotic Surgical Procedures, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Esophageal adenocarcinoma incidence is increasing in Western nations. There has been a shift toward minimally invasive approaches for transhiatal esophagectomy (THE). This study compares the outcomes of robotic THE for esophageal adenocarcinoma resection at our institution with the predicted metrics from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). With Institutional Review Board (IRB) approval, we prospectively followed 83 patients who underwent robotic THE from 2012 to 2023. Predicted outcomes were determined using the ACS NSQIP Surgical Risk Calculator. Our outcomes were compared with these predicted outcomes and with general outcomes for transhiatal esophagectomy reported in ACS NSQIP, which includes a mix of surgical approaches. The median age of patients was 70 years, with a body mass index (BMI) of 26.4 kg/m2 and a male prevalence of 82%. The median length of stay was 7 days. The rates of any complications and in-hospital mortality were 16% and 5%, respectively. Seven patients (8%) were readmitted within a 30-day postoperative window. The median survival is anticipated to surpass 95 months. Our outcomes were generally aligned with or surpassed the predicted ACS NSQIP metrics. The extended median survival of over 95 months highlights the potential effectiveness of robotic THE in the resection of esophageal adenocarcinoma. Further exploration into its long-term survival benefits and outcomes is warranted, along with studies that provide a more direct comparison between robotic and other surgical approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Foregut and HPB Division, Digestive Health Institute, AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA. mysharonaross@gmail.com.
- Foregut and HPB Division, Digestive Health Institute, AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
- Rosalind Franklin University of Medicine and Science (Chicago) Medical School, North Chicago, USA.
Zitieren
APA
Ross, S. B., Peek, G., Sucandy, I., Pattilachan, T. M., Christodoulou, M., & Rosemurgy, A. (2024). A comparative assessment of ACS NSQIP-predicted and actual surgical risk outcomes of robotic transhiatal esophagectomy for esophageal adenocarcinoma resection at a high volume institution. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-024-02034-1
Vancouver
Ross SB, Peek G, Sucandy I, Pattilachan TM, Christodoulou M, Rosemurgy A. A comparative assessment of ACS NSQIP-predicted and actual surgical risk outcomes of robotic transhiatal esophagectomy for esophageal adenocarcinoma resection at a high volume institution. Journal of Robotic Surgery. 2024. doi:10.1007/s11701-024-02034-1
BibTeX
@article{Ross2024,
author = {Ross, Sharona B and Peek, George and Sucandy, Iswanto and Pattilachan, Tara M and Christodoulou, Maria and Rosemurgy, Alexander},
title = {A comparative assessment of ACS NSQIP-predicted and actual surgical risk outcomes of robotic transhiatal esophagectomy for esophageal adenocarcinoma resection at a high volume institution},
journal = {Journal of Robotic Surgery},
year = {2024},
doi = {10.1007/s11701-024-02034-1}
}
EUVIMED